FDA warns Curaleaf about inflated claims in CBD product marketing
4 years ago
19
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
1:23
WFTX
9 months agoMarco Patriots headed home after helping people impacted by Idalia
528 -
0:42
KMGH
2 years agoBBB warns about travel scams
49 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
44 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
11 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
13:32
Bearing
9 hours ago"Biden Totally Won" Lefties COPE HARD Over Trump Debate
5.94K16 -
1:58:14
Revenge of the Cis
4 hours agoEpisode 1346: Doctor Death
37.4K17 -
2:01:02
Film Threat
8 hours agoVERSUS: THE ACOLYTE VS. HOUSE OF THE DRAGON | Film Threat Versus
26.7K1